FFAM
TLSIW icon

Forge First Asset Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Forge First Asset Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-49,133
Closed -$3.94K – 50
2023
Q1 		$3.94K Hold
49,133
– – ﹤0.01% 39
2022
Q4 		$3.69K Buy
+49,133
New +$3.33K ﹤0.01% 35

Other funds holding TLSIW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Forge First Asset Management's TLSIW Position: Q2 2023 in Review

Forge First Asset Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q2 2023, closing a stake of 49,133 shares — an estimated $3.94K sold.

Forge First Asset Management first reported a position in TLSIW in Q4 2022 and held it in 2 quarters. The position peaked at $3.94K in Q1 2023. 23 funds tracked by Wall St. Rank hold TLSIW as of Q2 2023.

  • Forge First Asset Management reported no remaining TriSalus Life Sciences Warrant position as of Q2 2023 after selling out during the quarter.
  • Forge First Asset Management sold 49,133 TriSalus Life Sciences Warrant shares in Q2 2023, an estimated $3.94K.
  • Forge First Asset Management first reported a position in TriSalus Life Sciences Warrant in Q4 2022 and held it in 2 quarters.
  • Forge First Asset Management's TriSalus Life Sciences Warrant position peaked at $3.94K in Q1 2023.
  • 23 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q2 2023.

Based on Forge First Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.